ATE393211T2 - Milchsäureproduzierende bakterien zur verwendung als probiotische organismen in der menschlichen scheide - Google Patents

Milchsäureproduzierende bakterien zur verwendung als probiotische organismen in der menschlichen scheide Download PDF

Info

Publication number
ATE393211T2
ATE393211T2 AT02780211T AT02780211T ATE393211T2 AT E393211 T2 ATE393211 T2 AT E393211T2 AT 02780211 T AT02780211 T AT 02780211T AT 02780211 T AT02780211 T AT 02780211T AT E393211 T2 ATE393211 T2 AT E393211T2
Authority
AT
Austria
Prior art keywords
lactic acid
bacterial strains
producing bacteria
acid producing
human vagina
Prior art date
Application number
AT02780211T
Other languages
English (en)
Inventor
Carolina Samuelsson
Endre Kvanta
Jiffer Anna Weiner
Original Assignee
Ellen Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20285385&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE393211(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ellen Ab filed Critical Ellen Ab
Application granted granted Critical
Publication of ATE393211T2 publication Critical patent/ATE393211T2/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/245—Lactobacillus casei
AT02780211T 2001-09-20 2002-09-19 Milchsäureproduzierende bakterien zur verwendung als probiotische organismen in der menschlichen scheide ATE393211T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0103127A SE521022C2 (sv) 2001-09-20 2001-09-20 Mjölksyraproducerande bakterier för användning som probiotiska organismer i vaginan hos människa

Publications (1)

Publication Number Publication Date
ATE393211T2 true ATE393211T2 (de) 2008-05-15

Family

ID=20285385

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02780211T ATE393211T2 (de) 2001-09-20 2002-09-19 Milchsäureproduzierende bakterien zur verwendung als probiotische organismen in der menschlichen scheide

Country Status (15)

Country Link
US (2) US7312067B2 (de)
EP (1) EP1427808B2 (de)
JP (1) JP4223955B2 (de)
CN (1) CN1308436C (de)
AT (1) ATE393211T2 (de)
AU (1) AU2002343282B2 (de)
CA (1) CA2459178C (de)
DE (1) DE60226254T3 (de)
ES (1) ES2305313T5 (de)
HK (1) HK1070385A1 (de)
IL (2) IL160937A0 (de)
PL (1) PL206760B1 (de)
SE (1) SE521022C2 (de)
WO (1) WO2003038068A1 (de)
ZA (1) ZA200401315B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE521022C2 (sv) * 2001-09-20 2003-09-23 Ellen Ab Mjölksyraproducerande bakterier för användning som probiotiska organismer i vaginan hos människa
SE526029C2 (sv) * 2003-05-13 2005-06-21 Sca Hygiene Prod Ab Hygien produkt innefattande bakteriepreparation och förfarande för dess framställning
US20060165661A1 (en) * 2003-06-13 2006-07-27 N>V> Nutricia Pediocin-producing pediococci
ES2237732T3 (es) * 2003-11-03 2005-08-01 Peter-Hansen Volkmann Composicion para el cuidado vaginal.
WO2006045347A1 (en) 2004-10-22 2006-05-04 Medinova Ag Lactobacillus helveticus strain useful in the treatment or prevention of infections caused by urogenital pathogens
EP1802318A1 (de) * 2004-10-22 2007-07-04 Medinova AG Milchsäurebakterien-stämme gegen gastrointestinale erreger und diese enthaltende zusammensetzungen
CA2627430C (en) * 2005-11-01 2012-10-16 Sideromics, Llc Growth control of oral and superficial microorganisms using gallium compounds
AU2006350773A1 (en) 2006-11-17 2008-05-22 Sca Hygiene Products Ab Sanitary article comprising a microbe-inhibiting composition
JP4829349B2 (ja) 2006-11-17 2011-12-07 エスセーアー・ハイジーン・プロダクツ・アーベー 微生物阻害組成物を含む衛生用テッシュ
WO2008060198A1 (en) * 2006-11-17 2008-05-22 Sca Hygiene Products Ab Lactobacillus fermentum ess-1, dsm17851 and its use for the treatment and/or prevention of candidiasis and urinary tracrinfections
US8642029B2 (en) * 2008-03-31 2014-02-04 Osel, Inc. Transiently buffered Lactobacillus preparations and use thereof
EP2158916A1 (de) 2008-08-27 2010-03-03 Ellen Aktiebolag Milchsäurebakterien enthaltende Verabreichungseinheit
CZ2009444A3 (cs) 2009-07-09 2010-09-01 Arko-Consult S.R.O. Prevence syndromu toxického šoku pomocí bakterií rodu Lactobacillus
KR101417557B1 (ko) * 2010-02-16 2014-07-22 플레이텍스 프로덕츠, 엘엘씨. 저 ｐｈ, 최적 ｏｒｐ 및 냄새 감소 섬유, 이 섬유의 제조방법 및 이로부터 제조된 물품
US9034593B2 (en) 2010-11-22 2015-05-19 Kimberly-Clark Worldwide, Inc. Vaginal indicator to detect biomarkers of good health
FR2992973B1 (fr) * 2012-07-09 2015-12-18 S P M D Nouvelle souche de lactobacillus crispatus
CN102727531A (zh) * 2012-07-23 2012-10-17 郑州金森生物科技工程有限公司 一种对阴道炎具有治疗和预防作用的活性乳酸菌胶囊
CN103074270A (zh) * 2012-11-15 2013-05-01 上海交大昂立股份有限公司 一种卷曲乳杆菌及其应用
WO2014106541A1 (en) 2013-01-04 2014-07-10 Ellen Ab Dermal composition for use in the external genital area in females
CN103911308A (zh) * 2013-01-05 2014-07-09 欣力菲生物医药技术（天津）有限公司 卷曲乳杆菌菌株及其用途
CN103911305B (zh) * 2013-01-05 2016-04-13 欣力菲生物医药技术（天津）有限公司 卷曲乳杆菌菌株及其用途
CN103911309B (zh) * 2013-01-05 2016-08-24 欣力菲生物医药技术（天津）有限公司 加氏乳杆菌菌株及其用途
CN103911307B (zh) * 2013-01-05 2016-04-13 欣力菲生物医药技术（天津）有限公司 卷曲乳杆菌菌株及其用途
CN103911306B (zh) * 2013-01-05 2016-08-24 欣力菲生物医药技术（天津）有限公司 加氏乳杆菌菌株及其用途
CN104630083B (zh) * 2013-11-08 2018-07-06 苏州欧赛微科生物医药科技有限公司 一种卷曲乳杆菌及其在妇女保健产品中的应用
CZ2014565A3 (cs) 2014-08-22 2016-03-02 Vysoká škola chemicko - technologická v Praze Kmeny laktobacilů produkující látky účinné proti vaginálním patogenům, jejich použití a hygienické prostředky je obsahující
CN104694413B (zh) * 2014-11-21 2018-04-17 北京百益恒源科技有限公司 一株弯曲乳酸杆菌（Lactobacillus crispatus）及其制药用途
US10588926B2 (en) * 2015-06-29 2020-03-17 Ferring B.V. Lactobacillus rhamnosus bacterium for treatment of e.g. bacterial vaginosis
US11166968B2 (en) 2015-09-29 2021-11-09 Kimberly-Clark Worldwide, Inc. Synergistic composition for maintenance of healthy balance of microflora
DE102015119941A1 (de) * 2015-11-10 2017-05-11 Delphi Beteiligungsgesellschaft mbH Neuartiger Hygieneartikel
EP3648778A4 (de) * 2017-07-07 2021-05-05 Osel, Inc. Hochwirksame stabile formulierungen von vaginalem lactobacillus
US20200206279A1 (en) * 2017-07-18 2020-07-02 Aobiome Llc Ammonia oxidizing microorganisms for use and delivery to the urogenital system
CN107899059A (zh) * 2017-10-30 2018-04-13 苏州宝丽洁医疗科技有限公司 一种消炎抗菌型卫生棉条及其制备方法
CN113512509B (zh) * 2021-05-07 2022-02-22 南方医科大学珠江医院 卷曲乳杆菌及其用途
CN113308405A (zh) * 2021-06-04 2021-08-27 青岛诺森生物技术有限责任公司 一种新型的双益生菌协同复合菌剂及其应用
CN113862188B (zh) * 2021-10-15 2023-06-16 广东一元兰欣生物科技有限公司 一株格氏乳杆菌ls03及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804179A (en) * 1985-12-31 1998-09-08 Research Corporation Technologies, Inc. Lactobacillus compositions and methods for treating urinary tract infections
IT1227154B (it) * 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
SE9100364L (sv) 1991-02-05 1992-08-06 Bac Dev In Sweden Ab Tampong eller binda impregnerad med en kultur av levande mjoelksyrabakterier i avsikt att minska risken foer urogenitala infektioner
GB2261372A (en) † 1991-11-15 1993-05-19 Gregor Reid Lactobacillus and skim milk compositions for prevention of urogenital infection
UA39965C2 (uk) 1993-12-03 2001-07-16 Лайфор Леборетріз Лтд Вірусоцидний, бактерицидний та руйнуючий сперматозоїди вагінальний засіб і вагінальний супозиторій ( варіанти )
US6180100B1 (en) * 1994-09-30 2001-01-30 Urex Biotech., Inc. Lactobacillus compositions and methods for treating urinary tract infections
CN1184637A (zh) * 1996-12-07 1998-06-17 大连医科大学科达药业有限公司 治阴道病的乳杆菌及制剂
DE19713908A1 (de) † 1997-04-04 1998-10-08 Symbio Herborn Group Gmbh & Co Vaginaltampon und Verfahren zu seiner Herstellung
US6093394A (en) * 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
SE519648C2 (sv) † 1998-03-06 2003-03-25 Essum Ab Ny stam av Lactobacillus plantarum
EP0956858B1 (de) * 1998-04-30 2001-10-31 Renata Maria Anna Cavaliere Vesely Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen
CA2354054C (en) 1998-12-11 2011-04-12 Urex Biotech, Inc. Oral administration of lactobacillus for the treatment and prevention of urogenital infection
AU4905300A (en) † 1999-05-25 2000-12-12 Andrew W. Bruce Oral administration of lactobacillus for the maintenance of health in women
SE521022C2 (sv) * 2001-09-20 2003-09-23 Ellen Ab Mjölksyraproducerande bakterier för användning som probiotiska organismer i vaginan hos människa

Also Published As

Publication number Publication date
PL369201A1 (en) 2005-04-18
EP1427808B1 (de) 2008-04-23
SE521022C2 (sv) 2003-09-23
DE60226254T3 (de) 2017-11-16
EP1427808A1 (de) 2004-06-16
JP2005507256A (ja) 2005-03-17
US20080057046A1 (en) 2008-03-06
CA2459178A1 (en) 2003-05-08
SE0103127D0 (sv) 2001-09-20
AU2002343282B2 (en) 2005-10-20
IL160937A0 (en) 2004-08-31
JP4223955B2 (ja) 2009-02-12
CN1308436C (zh) 2007-04-04
US7312067B2 (en) 2007-12-25
DE60226254D1 (de) 2008-06-05
DE60226254T2 (de) 2009-06-25
ES2305313T5 (es) 2017-11-13
CN1556852A (zh) 2004-12-22
EP1427808B2 (de) 2017-06-28
CA2459178C (en) 2013-01-22
US20040253217A1 (en) 2004-12-16
ZA200401315B (en) 2005-05-25
SE0103127L (sv) 2003-03-21
HK1070385A1 (en) 2005-06-17
IL160937A (en) 2011-05-31
ES2305313T3 (es) 2008-11-01
WO2003038068A1 (en) 2003-05-08
PL206760B1 (pl) 2010-09-30

Similar Documents

Publication Publication Date Title
ATE393211T2 (de) Milchsäureproduzierende bakterien zur verwendung als probiotische organismen in der menschlichen scheide
JP3993168B2 (ja) ラクトバシルス・ペントサス株を含む組成物およびそれらの使用
DE69930944D1 (de) Bacillus coagulans-zusammensetzung und deren verwendung
KR102146146B1 (ko) 프로바이오틱으로서 락토바실러스 펜토수스의 균주
ATE439138T1 (de) Probiotika zur primären prävention atopischer erkrankungen
ATE290391T1 (de) Orale verabreichung von laktobacillus zur behandlung und prävention von urogenitalen infektionen
CO4830476A1 (es) Nuevo agente
JP2010509982A (ja) 微生物阻害組成物を含む衛生用品
US10806760B2 (en) Compositions and methods for reducing flatulence
CO5700799A2 (es) Nuevo producto
CA2570062A1 (en) Lactic bacteria and their use in the prevention of diarrhea
MXPA04005002A (es) Bacterias lacticas y su uso en el tratamiento y la prevencion del cancer.
Zhao et al. In vitro assessment of probiotic properties of lactic acid bacteria isolated from vaginas of healthy cows
Das et al. Prophylactic application of vaginal lactic acid bacteria against urogenital pathogens and its prospective use in sanitary suppositories
KR20150075447A (ko) 여성 자궁 질염 예방 및 개선 기능성 조성물
Kilic et al. Susceptibility to some antifungal drugs of vaginal lactobacilli isolated from healthy women
WO2023281415A3 (en) Bacteria strains for topical skin care
Esteban-Fernández et al. In vitro beneficial effects of Streptococcus dentisani as potential

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1427808

Country of ref document: EP